These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 11394572)

  • 21. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.
    Muerhoff AS; Gutierrez R; Kyrk C; Leary T; Schlauder G; Dawson G; Desai SM
    J Med Virol; 2008 Mar; 80(3):411-8. PubMed ID: 18205228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of polypeptide antigen of HCVE2/NS1 relative conservation region in detection of anti-HCV].
    Li Q; Hu X; Min F
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):61-3. PubMed ID: 12759957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen.
    Wei SH; Yin W; An QX; Lei YF; Hu XB; Yang J; Lu X; Zhang H; Xu ZK
    Arch Virol; 2008; 153(6):1021-9. PubMed ID: 18421415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.
    Burioni R; Mancini N; Carletti S; Perotti M; Grieco A; Canducci F; Varaldo PE; Clementi M
    Virology; 2004 Oct; 327(2):242-8. PubMed ID: 15351212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C.
    Ishii K; Rosa D; Watanabe Y; Katayama T; Harada H; Wyatt C; Kiyosawa K; Aizaki H; Matsuura Y; Houghton M; Abrignani S; Miyamura T
    Hepatology; 1998 Oct; 28(4):1117-20. PubMed ID: 9755251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.
    Baumert TF; Wellnitz S; Aono S; Satoi J; Herion D; Tilman Gerlach J; Pape GR; Lau JY; Hoofnagle JH; Blum HE; Liang TJ
    Hepatology; 2000 Sep; 32(3):610-7. PubMed ID: 10960457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant hepatitis C virus-like particles expressed by baculovirus: utility in cell-binding and antibody detection assays.
    Xiang J; Wünschmann S; George SL; Klinzman D; Schmidt WN; LaBrecque DR; Stapleton JT
    J Med Virol; 2002 Dec; 68(4):537-43. PubMed ID: 12376962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment.
    Penin F; Combet C; Germanidis G; Frainais PO; Deléage G; Pawlotsky JM
    J Virol; 2001 Jun; 75(12):5703-10. PubMed ID: 11356980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cloning and sequencing of cDNA of E2/NS1 gene of hepatitis C virus].
    Shen D; Lu H; Li M; He L; Shang D; Ma X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):227-31. PubMed ID: 15617335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of human immune response to potential hepatitis C viral epitopes.
    Khanna A; Poduri CD; Murugan P; Kumar S; Sugunan VS; Shenoy KT; Das MR
    Acta Virol; 1998 Jun; 42(3):141-5. PubMed ID: 9842443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical significance of N-14 antibody (ELISA) in diagnosis of non-A, non-B liver disease].
    Yone Y
    Fukuoka Igaku Zasshi; 1992 Apr; 83(4):156-67. PubMed ID: 1318860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures.
    Shimizu YK; Igarashi H; Kiyohara T; Cabezon T; Farci P; Purcell RH; Yoshikura H
    Virology; 1996 Sep; 223(2):409-12. PubMed ID: 8806581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of extensive genetic heterogeneity of hepatitis C virus in antibody-negative chronic hepatitis C.
    Kao JH; Chen PJ; Yang PM; Lai MY; Wang TH; Chen DS
    J Med Virol; 1996 Jun; 49(2):87-90. PubMed ID: 8991941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple sequence-reactive antibodies induced by a single peptide immunization with hypervariable region 1 of hepatitis C virus.
    Zhou YH; Moriyama M; Esumi M
    Virology; 1999 Apr; 256(2):360-70. PubMed ID: 10191201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C.
    Steinmann D; Barth H; Gissler B; Schürmann P; Adah MI; Gerlach JT; Pape GR; Depla E; Jacobs D; Maertens G; Patel AH; Inchauspé G; Liang TJ; Blum HE; Baumert TF
    J Virol; 2004 Sep; 78(17):9030-40. PubMed ID: 15308699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to a novel antigen in acute hepatitis C virus infections.
    Tobler LH; Stramer SL; Chien DY; Lin S; Arcangel P; Phelps BH; Cooper SL; Busch MP
    Vox Sang; 2007 Jan; 92(1):1-7. PubMed ID: 17181584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoglobulin G antibody avidity assay for serodiagnosis of hepatitis C virus infection.
    Kanno A; Kazuyama Y
    J Med Virol; 2002 Oct; 68(2):229-33. PubMed ID: 12210412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Broadly cross-reactive, high-affinity antibody to hypervariable region 1 of the hepatitis C virus in rabbits.
    Shang D; Zhai W; Allain JP
    Virology; 1999 Jun; 258(2):396-405. PubMed ID: 10366577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins.
    Sarobe P; Lasarte JJ; García N; Civeira MP; Borrás-Cuesta F; Prieto J
    J Viral Hepat; 2006 Jan; 13(1):47-55. PubMed ID: 16364082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.